CEO of ACTOVERCO during the visit of Alireza Zali, Commander of Corona Headquarters in Tehran Noting that the Octovorco Research and Development Group has been producing Corona pandemics since its inception Corona treatment drugs have tried a lot "In this regard, we have succeeded in producing drugs such as favipiravir, remedsivir, and ivermectin," she said. However, what breaks the chain of the Coronavirus outbreak is the corona vaccine.
According to the October Group Public Relations, Nahaleh Naraghi added: In October, Biotech started a project to produce the Corona vaccine, And the experiment was performed successfully on mice And last week, rhesus monkeys were prepared for testing. Of course, this project is time-consuming, and I think if we want to produce a standard vaccine And even get WHO approval, It takes at least 10 to 12 months. For this reason, until then and in parallel with the production of domestic vaccines We must seek valid foreign corona vaccines that also have international approvals.
She added: "Octovorco has entered into a partnership with a foreign company to produce the corona vaccine." Preliminary agreements have also been reached, which, if finalized, will be a national honor In addition to the domestic market, we can supply the corona vaccine even to the markets of the countries in the region. Production infrastructure in the Octover plant has been prepared and successfully updated.
Production infrastructure in the Octover plant has been prepared and successfully updated. Production standards in October are very high and we are ready to produce the corona vaccine. We hope we can By obtaining the necessary permits from the Ministry of Health and the foreign side from April Start production of 1400 corona vaccines with international standard.